Back to Clinical Trials

Clinical Trials: Medical Licensing Exams


Source: Nanotherapeutics, Inc.
The purpose of this study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to World Heath Organization/European Union (WHO/EU) recommendation for the 2009/2010 season for yearly licensing application. Read More
Last Updated: 06 Oct 2015
Source: National Institutes of Health Clinical Center (CC)
Background: - Automobile crash risks are highest right after licensure and decline rapidly for about 6 months and then gradually for years, regardless of the amount of supervised practice driving or age at licensure. The only approaches to this problem that have demonstrated effectiveness are Graduated Driver Licensing (GDL) and parental management. - The Checkpoints Program consists of persuasive messages and materials designed to ... Read More
Last Updated: 23 Jan 2017
Source: Crucell Holland BV
The study is to assess whether the influenza vaccine Inflexal V for season 2013/2014 fulfills the EMA requirements for re-registration of influenza vaccines. Read More
Last Updated: 28 Aug 2013
Source: Baxter Healthcare Corporation
The purpose of the study is to verify the immunogenicity and tolerance of a trivalent seasonal influenza vaccine with strain composition according to WHO/EU recommendation for the 2010/2011 season for yearly licensing application. Read More
Last Updated: 22 Aug 2010
Source: University of Illinois at Chicago
During the project, fourth-year medical students participating in a Medicine sub-internship will be randomized to an intervention group or a control group; the intervention group will receive additional training in the application of qualitative methodology to elicit and incorporate contextual factors in the clinical encounter. All students will participate in an SP assessment consisting of four standardized patients (SPs), blinded to trial arm, presenting ... Read More
Last Updated: 10 Apr 2011
Source: Novartis
To evaluate the safety of a single intramuscular (IM) injection of trivalent nonadjuvated influenza study vaccine, formulation 2012/2013, in adult and elderly subjects and the antibody response to each influenza vaccine antigen, as measured by single radial hemolysis (SRH) and hemagglutination inhibition (HI) at approximately 21 days postimmunization in adult and elderly subjects in compliance with the requirements of the current EU recommendations for ... Read More
Last Updated: 01 Nov 2015
Source: Crucell Holland BV
This study is to assess whether the Northern Hemisphere 2009/2010 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines. Read More
Last Updated: 28 Aug 2013
Source: Crucell Holland BV
A study to assess whether the Northern Hemisphere 2010/2011 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines Read More
Last Updated: 28 Aug 2013
Source: Crucell Holland BV
The study is to assess whether the virosomal influenza vaccine for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines. Read More
Last Updated: 18 Dec 2013
Source: Crucell Holland BV
A study to assess whether the Northern Hemisphere 2008/2009 season influenza vaccine Inflexal V fulfills the EMEA requirements for re-registration of influenza vaccines Read More
Last Updated: 28 Aug 2013
Source: Assuta Medical Center
A comparative prospective study to evaluate different imaging modalities (pet-ct and pet-mr) prior to surgery in parathyroid tumor patients. Read More
Last Updated: 20 Jul 2016
Source: Crucell Holland BV
The study is to assess whether the influenza vaccine Inflexal V for season 2012/2013 fulfills the EMA requirements for re-registration of influenza vaccines. Read More
Last Updated: 18 Dec 2013
Source: University of Pennsylvania
The mailer will encourage all employees of one of Evive's partner companies to attend an on-site free flu shot clinic they are offering in the fall of 2011. The research will examine differences in follow-through on getting a flu shot at an on-site clinic among the targeted population during the ~1 month period when clinics are being offered (following the mailing) as a function of experimental condition. Read More
Last Updated: 12 Sep 2016
Source: GlaxoSmithKline
Following licensing of PoliorixTM in Korea, this study will collect safety data about the routine use of this vaccine in 600 children according to the regulations of Korean Food and Drugs Administration (KFDA). Read More
Last Updated: 14 Mar 2012
Source: Novartis
The present study is designed to confirm the safety and immunogenicity of trivalent, surface antigen, inactivated influenza vaccine in 2 age cohorts: 18 to ≤60 years and ≥61 years and the antibody response to each influenza vaccine antigen, as measured by Single Radial Hemolysis (SRH) or Hemagglutination Inhibition (HI) at approximately 21 days post immunization. The vaccine composition will be based on the World Health Organization (WHO) recommended ... Read More
Last Updated: 09 Feb 2014
Source: GlaxoSmithKline
A pre-requisite to the yearly licensing process of the Influenza vaccine (FluarixTM/ Influsplit SSW®) is to demonstrate in clinical studies, the immunogenicity and reactogenicity of the vaccine composed of the new strains (2005/2006). Read More
Last Updated: 19 Sep 2016
Source: Novartis
To evaluate the safety of a single intramuscular (IM) injection of trivalent adjuvanted influenza study vaccine, formulation 2012/2013, in elderly subjects and the antibody response to each influenza vaccine antigen, as measured by single radial hemolysis (SRH) and hemagglutination inhibition (HI) at approximately 21 days postimmunization in elderly subjects in compliance with the requirements of the current EU recommendations for clinical trials related to ... Read More
Last Updated: 02 Apr 2014
Source: Novartis
The purpose of this study is to evaluate the safety of a single intramuscular (IM) injection of the cell derived subunit trivalent nonadjuvanted influenza vaccine in adult and elderly subjects and the antibody response to each influenza vaccine antigen, as measured by hemagglutination inhibition (HI) at approximately 21 days postimmunization in adult and elderly subjects in compliance with the requirements of the current EU recommendations for clinical ... Read More
Last Updated: 18 Jan 2016
Source: Washington University School of Medicine
The purpose of this study is to assess the safety and tolerability of dantrolene sodium in patients with Wolfram syndrome. Wolfram syndrome is a rare genetic disorder, causing diabetes mellitus, optic atrophy, and deafness as well as various other possible disorders including premature death in most patients. There is a screening period up to 28 days, a 24-week treatment period, and a 4-week safety follow-up period. Study assessments include medical & ... Read More
Last Updated: 12 Oct 2016
Source: Sunnybrook Health Sciences Centre
Based on the literature on dementia and driving, and on knowledge tools available to date including one from our current work, a Driving in Mild Dementia Decision Tool (DMD-DT) will be adapted and tailored to guide physicians in their decisions to report a driver with mild dementia to the provincial licensing agency. The DMD-DT intervention will include a) an algorithm-based computerized clinical decision support system (CCDSS) for facilitating driving ... Read More
Last Updated: 08 Feb 2016
Page 1 of 50